Gilead aims remdesivir supply for 2 million Covid-19 patients by year-end

The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, currently administered only intravenously

from Companies https://ift.tt/2Z3xmm4
via IFTTT